Skip to main content
. 2020 Jan 8;21(1):45–57. doi: 10.1080/15532739.2019.1692750

Table 1.

Characteristics of the AMAB study population.

  Transgender women (196) Gender non binary people (44) Cross-dressers (14) Total (329) Differences between groups
Age (median) (years) [P25 – P75] 41.0 [29.0 – 51.0] 47.5 [35.3 – 56.0] 50.5 [46.0 – 56.5] 43.0 [31.0 – 53.0] P = 0.003*
Sexually attracted to Men 38 (19.4%) 10 (22.7%) 2 (14.3%) 50 (19.7%) P = 0.763
Women 78 (39.8%) 19 (43.2%) 7 (50.0%) 104 (40.9%) P = 0.701
Both 65 (33.2%) 20 (45.5%) 3 (21.4%) 88 (34.6%) P = 0.190
Transgender people 50 (25.5%) 15 (34.1%) 8 (57.1%) 73 (28.7%) P = 0.035
I don’t think gender is important 40 (20.4%) 9 (20.5%) 0 49 (19.3%) P = 0.170
No one 17 (8.7%) 2 (4.5%) 1 (7.1%) 20 (7.9%) P = 0.168
I don’t know 18 (9.2%) 1 (2.3%) 1 (7.1%) 20 (7.9%) P = 0.311
Other 25 (12.8%) 7 (15.9%) 1 (7.1%) 33 (13.0%) P = 0.774
Educational level Low - Medium 104 (53.1%) 18 (40.9%) 5 (35.7%) 127 (50.0%) P = 0.193
  High 92 (46.9%) 26 (59.1%) 9 (64.3%) 127 (50.0%)  
Household under economical stress (n yes) 66 (33.7%) 14 (31.8%) 0 80 (31.5%) P = 0.023*
Region Brussels Capital Region 17 (8.7%) 5 (11.4%) / 22 (8.7%) P = 0.274
  Flanders 139 (70.9%) 32 (72.7%) 14 (100.0%) 185 (72.8%)  
  Wallonia 35 (17.9%) 7 (15.9%) / 42 (16.5%)  
Previously contacted a health care professional 167 (85.2%) 23 (52.3%) 6 (42.9%) 196 (77.2%) P < 0.001*
Initiated gender affirming therapy Mental health 167 (85.2%) 11 (25.0%) 1 (7.1%) 179 (70.5%) P < 0.001*
Gender affirming hormones 134 (68.4%) 9 (20.5%) 0 143 (56.3%) P < 0.001*
Breast augmentation 44 (22.4%) 2 (4.5%) 0 46 (18.1%) P = 0.149
Orchiectomy 54 (27.6%) 1 (2.3%) 0 55 (21.7%) P = 0.010*
  Vaginoplasty 50 (25.5%) 1 (2.3%) 0 51 (20.1%) P = 0.017*